Testosterone Undeconate (Nebido, BAY86-5037) + Placebo
ApprovedTerminated 0 watching 0 views this week๐ฅ Hot
82
Development Stage
โ
Pre-clinicalโ
Phase 1โ
Phase 2โ
Phase 35
ApprovedIndication / Disease
Hypogonadism
Conditions
Hypogonadism
Trial Timeline
Sep 1, 2010 โ Jul 1, 2011
NCT ID
NCT01092858About Testosterone Undeconate (Nebido, BAY86-5037) + Placebo
Testosterone Undeconate (Nebido, BAY86-5037) + Placebo is a approved stage product being developed by Bayer for Hypogonadism. The current trial status is terminated. This product is registered under clinical trial identifier NCT01092858. Target conditions include Hypogonadism.
Hype Score Breakdown
Clinical
30
Activity
20
Company
7
Novelty
10
Community
12
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01092858 | Approved | Terminated |
Competing Products
20 competing products in Hypogonadism